Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study

被引:1
作者
Tang, Shi-Chuan [1 ,2 ,3 ]
Wu, Ye-Ye [4 ]
Lin, Zhi-Wen [3 ]
Chen, Qing-Jing [1 ,2 ,3 ]
Luo, Cong [5 ]
Li, Yun-Tong [6 ]
Fu, Jun [3 ]
Zheng, Li-Fang [3 ]
You, Peng-Hui [7 ]
You, Song [3 ]
You, Wu-Yi [8 ]
Lin, Ke-Can [3 ]
Zhou, Wei-Ping [9 ]
Lin, Kong-Ying [1 ,2 ,3 ]
Zeng, Yong-Yi [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Med Coll, Clin 1, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[3] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[4] Second Mil Med Univ, Navy Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surgery2, Shanghai, Peoples R China
[5] Peoples Hosp Zizhong Cty, Dept Hepatopancreatobiliary Surg, Zizhong, Peoples R China
[6] Xiamen Univ, Dept Hepatobiliary Surg, ZhongShan Hosp, Xiamen, Peoples R China
[7] Fujian Med Univ, Bioinformat Sample Bank, Biobank Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[8] Fujian Med Univ, Dept Radiat, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[9] Navy Med Univ, Mil Med Univ 2, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; alpha-fetoprotein; des-gamma (gamma)-carboxy prothrombin; resection; prognosis; CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; TUMOR-MARKERS; DIAGNOSIS; RECURRENCE; SURVIVAL; ABLATION; MODEL;
D O I
10.3389/fonc.2024.1425292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The utility of pre- and post-operative alpha-fetoprotein (AFP) and des-gamma (gamma)-carboxy prothrombin (DCP) expression patterns and their dynamic changes as predictors of the outcome of hepatic resection for hepatocellular carcinoma (HCC) has yet to be well elucidated. Methods: From a multicenter database, AFP and DCP data during the week prior to surgery and the first post-discharge outpatient visit (within 1-2 months after surgery) were collected from patients with HCC who underwent hepatectomy. AFP-DCP expression patterns were categorized according to the number of positive tumor markers (AFP >= 20ng/mL, DCP >= 40mAU/mL), including double-negative, single-positive, and double-positive. Changes in the AFP-DCP expression patterns were delineated based on variations in the number of positive tumor markers when comparing pre- and post-operative patterns. Results: Preoperatively, 53 patients (8.3%), 337 patients (52.8%), and 248 patients (38.9%) exhibited double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Postoperatively, 463 patients (72.6%), 130 patients (20.4%), and 45 patients (7.0%) showed double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Survival analysis showed a progressive decrease in recurrence-free (RFS) and overall survival (OS) as the number of postoperative positive tumor markers increased (both P < 0.001). Multivariate analysis showed that postoperative AFP-DCP expression pattern, but not preoperative AFP-DCP expression pattern, was an independent risk factor for RFS and OS. Further analysis showed that for patients with positive preoperative markers, prognosis gradually improves as positive markers decrease postoperatively. In particular, when all postoperative markers turned negative, the prognosis was consistent with that of preoperative double-negative patients, regardless of the initial number of positive markers. Conclusions: AFP-DCP expression patterns, particularly postoperative patterns, serve as vital sources of information for prognostic evaluation following hepatectomy for HCC. Moreover, changes in AFP-DCP expression patterns from pre- to post-operation enable dynamic prognostic risk stratification postoperatively, aiding the development of individualized follow-up strategies.
引用
收藏
页数:14
相关论文
共 38 条
[1]   The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma [J].
Bai, Dou-Sheng ;
Zhang, Chi ;
Chen, Ping ;
Jin, Sheng-Jie ;
Jiang, Guo-Qing .
SCIENTIFIC REPORTS, 2017, 7
[2]   Hepatobiliary Cancers, Version 2.2021 [J].
Benson III, Al B. ;
D'Angelica, Michael I. ;
Abbott, Daniel E. ;
Anaya, Daniel A. ;
Anders, Robert ;
Are, Chandrakanth ;
Bachini, Melinda ;
Borad, Mitesh ;
Brown, Daniel ;
Burgoyne, Adam ;
Chahal, Prabhleen ;
Chang, Daniel T. ;
Cloyd, Jordan ;
Covey, Anne M. ;
Glazer, Evan S. ;
Goyal, Lipika ;
Hawkins, William G. ;
Iyer, Renuka ;
Jacob, Rojymon ;
Kelley, R. Kate ;
Kim, Robin ;
Levine, Matthew ;
Palta, Manisha ;
Park, James O. ;
Raman, Steven ;
Reddy, Sanjay ;
Sahai, Vaibhav ;
Schefter, Tracey ;
Singh, Gagandeep ;
Stein, Stacey ;
Vauthey, Jean-Nicolas ;
Venook, Alan P. ;
Yopp, Adam ;
McMillian, Nicole R. ;
Hochstetler, Cindy ;
Darlow, Susan D. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (05) :541-565
[3]   α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma [J].
Chen, LT ;
Liu, TW ;
Chao, Y ;
Shiah, HS ;
Chang, JY ;
Juang, SH ;
Chen, SC ;
Chuang, TR ;
Chin, YH ;
Whang-Peng, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (03) :217-226
[4]   Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update [J].
Cong, Wen-Ming ;
Bu, Hong ;
Chen, Jie ;
Dong, Hui ;
Zhu, Yu-Yao ;
Feng, Long-Hai ;
Chen, Jun .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (42) :9279-9287
[5]   Tumour evolution in hepatocellular carcinoma [J].
Craig, Amanda J. ;
Von Felden, Johann ;
Garcia-Lezana, Teresa ;
Sarcognato, Samantha ;
Villanueva, Augusto .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (03) :139-152
[6]   Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma [J].
Fujiki, M. ;
Takada, Y. ;
Ogura, Y. ;
Oike, F. ;
Kaido, T. ;
Teramukai, S. ;
Uemoto, S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (10) :2362-2371
[7]  
FURUKAWA M, 1992, CANCER-AM CANCER SOC, V69, P31, DOI 10.1002/1097-0142(19920101)69:1<31::AID-CNCR2820690108>3.0.CO
[8]  
2-6
[9]   Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma [J].
Kelley, Robin Kate ;
Meyer, Tim ;
Rimassa, Lorenza ;
Merle, Philippe ;
Park, Joong-Won ;
Yau, Thomas ;
Chan, Stephen L. ;
Blanc, Jean-Frederic ;
Tam, Vincent C. ;
Tran, Albert ;
Dadduzio, Vincenzo ;
Markby, David W. ;
Kaldate, Rajesh ;
Cheng, Ann-Lii ;
El-Khoueiry, Anthony B. ;
Abou-Alfa, Ghassan K. .
CLINICAL CANCER RESEARCH, 2020, 26 (18) :4795-4804
[10]   High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular Carcinoma [J].
Kobayashi, Masahiro ;
Ikeda, Kenji ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Hosaka, Tetsuya ;
Sezaki, Hitomi ;
Akuta, Norio ;
Suzuki, Fumitaka ;
Suzuki, Yoshiyuki ;
Saitoh, Satoshi ;
Arase, Yasuji ;
Kumada, Hiromitsu .
CANCER, 2009, 115 (03) :571-580